When.com Web Search

  1. Ads

    related to: do statins reduce mortality numbers in men over 50 mayo clinic chart

Search results

  1. Results From The WOW.Com Content Network
  2. Statins may lower risk for heart disease and death, even in ...

    www.aol.com/lifestyle/statins-may-lower-risk...

    The findings show a decrease in mortality among people 60 years of age and older — including people over the age of 85 — who took statins. The study is published in Annals of Internal Medicine .

  3. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    The small number of available trials do not support the use of statins as an adjunctive therapy or as a monotherapy in multiple sclerosis. [223] A modelling study in the UK funded by the NIHR found that people aged 70 and older who take statins live longer in good health than those who do not, regardless of whether they have cardiovascular disease.

  4. Atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Atorvastatin

    Hemodialysis: Although there has been moderate-to-high quality of evidence to show the lack of clear and significant clinical benefits of statins (including atorvastatin at a dose of 20mg) minimizing non-fatal myocardial infarction, stroke, and cardiovascular mortality in adults on hemodialysis (including those with diabetes and/or pre-existing ...

  5. Older adults over age 70 should consider taking statins ...

    www.aol.com/older-adults-over-age-70-151519096.html

    When examining the cost-effectiveness of statin use in older adults, the researchers report that statins were cost-effective, with the cost per quality-adjusted life years gained below £3,502 ...

  6. Statins are Effective Even for People Over Age 75, What ... - AOL

    www.aol.com/lifestyle/statins-effective-even...

    Statins appear to be effective at preventing cardiovascular disease and death in older adults, according to new research. Most clinical trials evaluating statins have not included people 75 and ...

  7. JUPITER trial - Wikipedia

    en.wikipedia.org/wiki/JUPITER_trial

    JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).